On September 10, 2025, Design Therapeutics, Inc., a biotechnology company listed on the Nasdaq under the ticker symbol DSGN, based in Carlsbad, California, disclosed the addition of Justin Gover to its Board of Directors. Gover, an experienced professional in the industry, joins the company to contribute his expertise in the development of treatments for severe degenerative genetic illnesses. This appointment takes effect immediately.